07:00 , May 5, 2014 |  BioCentury  |  Finance

Sweet sound

Sweet sound Mezzanine investors lined up for Otonomy Inc. 's $49 million series D round as the ear disorder play ramps up to launch its first product in 2016. Last week's round included new investors...
07:00 , Aug 3, 2009 |  BC Week In Review  |  Clinical News

CiproDex regulatory update

Alcon disclosed that last quarter it submitted regulatory applications in certain EU countries for Cilodex otic suspension to treat middle and outer ear infections. The company expects decisions in late 2010. Alcon already markets the...